More Transparency Needed for Vaccine Trials

AstraZeneca issued a press release announcing that clinical trials for their coronavirus vaccine, AZD1222, under development resumed last week in the UK. The vaccine AZD1222 was co-invented by the University of Oxford and its spin-off company, Vaccitech. It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus)…

COVID-19 vaccine

The European Commission says it has concluded exploratory talks with CureVac to purchase a potential vaccine against COVID-19.  This is following the positive steps with Sanofi-GSK on 31 July and Johnson and Johnson on 13 August and the signature of an Advance Purchase Agreement with AstraZeneca on 14 August. The envisaged contract with CureVac would…